Evaluation of Counteraction Potential of ZnO-NPs and/or <i>Piperacillin-Tazobactam</i> against Multi-Drug Resistant <i>Pseudomonas aeruginosa</i> and MCF-7 and HepG2 Cell Lines

Abstract

Nanotechnology offers promising opportunities in combating infectious agents, especially multidrug-resistant bacteria (MDR), which is a major concern in modern times. Zinc oxide nanoparticles (ZnO-NPs) are effective in delivering therapeutic agents to living systems due to their biocompatibility and bioactivity, making them effective against infectious microbes and also allowing them to be